4 completed, 3 recruiting, 2 not yet recruiting, 2 terminated. 5 Phase 1, 3 Phase 2, 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Recruiting 2, Terminated 2, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Endometrial: new trials by email Literature Review of Endometrial trials Research Report on Endometrial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors TS-104 - NSCLC (Non-small Cell Lung Cancer), HNSCC | Phase 1 | Recruiting | TwoStep Therapeutics, Inc. | 74 | 2026-09-02 | 2026-09-30 |
| Asymptomatic Women With Thick Endometrium: Hysteroscopic and Histopathological Report Endometrial, Asymptomatic Post-menopause | Not yet recruiting | Sohag University | 120 | 2026-08-01 | 2026-07-10 | |
| Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer Avutometinib, defactinib, Everolimus - Phase IB, Avutometinib | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 31 | 2026-05-13 | 2026-06-29 |
| Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion preoperative stoma identification and education - Colorectal Anastomosis, Endometrial | Not applicable | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 100 | 2026-03-01 | 2025-11-18 |
| Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. Zanidatamab - Non-Small Cell Lung Cancer, Sarcoma | Phase 2 | Recruiting | UNICANCER | 105 | 2025-10-30 | 2025-12-19 |
| A Study of SGN-MesoC2 in Advanced Solid Tumors PF-08052666 - Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms | Phase 1 | Terminated | Seagen, a wholly owned subsidiary of Pfizer | 19 | 2024-08-02 | 2026-07-07 |
| Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. PF-07224826, Fulvestrant - Breast Cancer, Ovarian Cancer | Phase 1 | Withdrawn | Pfizer | 2024-01-15 | 2023-11-08 | |
| Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin Tranexamic Acid, Calcium dobesilate (Doxium) - Heavy. Mentrual Bleeding, Abormal utèrine Bleeding | Phase 2 / Phase 3 | Completed | District Headquarters Teaching Hospital Sahiwal | 100 | 2022-01-01 | 2024-11-27 |
| EFFECTIVENESS OF PREOPERATIVE VAGINAL CLEANING IN REDUCING POST CAESAREAN INFECTIOUS MORBIDITY Vaginal cleaning, Non vaginal cleansing - Endometrial, Infection | Not applicable | Completed | Khyber Teaching Hospital | 76 | 2021-02-01 | 2025-07-08 |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) Temsirolimus, Irinotecan, Irinotecan + capecitabine - Advanced Cancer, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | Western Regional Medical Center | 33 | 2015-04-01 | 2018-07-02 |
| Endometrial Gene Expression in Different Protocols of Endometrial Preparation for Embryo Transfer' Endometrial Biopsy - Endometrial | Completed | IVI Madrid | 5 | 2014-12-01 | 2016-02-23 | |
| Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols Prostate, Brain | Completed | National Cancer Institute (NCI) | 903 | 2000-09-11 | 2019-12-12 |
Carcinoma, Non-Small-Cell Lung (5) · Colorectal Neoplasms (3) · Ovarian Neoplasms (3) · Head and Neck Neoplasms (2) · Adenomatous Polyposis Coli (1) · Agranulocytosis (1) · Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Hemorrhage (1) · Infections (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms by Site (6) · Bronchial Neoplasms (5) · Carcinoma, Bronchogenic (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Gastrointestinal Diseases (5) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Respiratory Tract Neoplasms (5) · Thoracic Neoplasms (5) · Urogenital Diseases (5)
Calcium Dobesilate (1) · Capecitabine (1) · Educational Status (1) · Everolimus (1) · Fulvestrant (1) · Irinotecan (1) · Nivolumab (1) · Tranexamic Acid (1) · defactinib (1) · temsirolimus (1) · zanidatamab (1)
Assistance Publique Hopitaux De Marseille (1) · District Headquarters Teaching Hospital Sahiwal (1) · IVI Madrid (1) · Khyber Teaching Hospital (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Pfizer (1) · Seagen, a wholly owned subsidiary of Pfizer (1) · Sohag University (1) · TwoStep Therapeutics, Inc. (1) · UNICANCER (1) · Western Regional Medical Center (1)
United States (5) · France (2) · Pakistan (2) · Canada (1) · Spain (1)
Cerrillo M Maria, doctor (1) · Cynthia Lynch, MD (1) · Dr Hira Hassan, MBBS FCPS (1) · Jordan Waypa, MSN, FNP (1) · Kevin A Camphausen, M.D. (1) · Shannon N Westin, MD (1)
PMID 29524595, PMID 31022078, PMID 33384016, PMID 34858760
2025 (1)